The decision by Health and Human Services (HHS) to end nearly $500 million in grants and contracts for developing mRNA vaccines has stirred concerns from BIO and others. What’s impacted: 22 projects ...

Last week’s agreement between European Union leadership and President Trump means tariffs on EU pharmaceutical imports could be around 15%. Why it matters: EU countries provide 43% of the active ...

A new BIO report outlines the state of early-stage funding for biotechs. Plus, during BIO 2025, legal experts unpacked IRA litigation—here’s what you should know. (761 words, 3 minutes, 48 seconds) ...

BIO hit the American road again, this time to Richmond, VA to meet with Virginia Bio, local entrepreneurs and patient advocates, and a company that's reshoring production of advanced pharmaceutical ...